Research Question, Study Design and Continuous Research Education and Training Exercises (CREATE) Program.
Abstract
The clinical research project starts with identifying the optimal research question,
one that is ethical, impactful, feasible, scientifically sound, novel, relevant, and
interesting. The project continues with the design of the study to answer the research
question. Such design should be consistent with ethical and methodological principles,
and make optimal use of resources in order to have the best chances of identifying
a meaningful answer to the research question. Physicians and other healthcare providers
are optimally positioned to identify meaningful research questions the answer to which
could make significant impact on healthcare delivery. The typical medical education
curriculum, however, lacks solid training in clinical research. We propose CREATE
(Continuous Research Education And Training Exercises) as a peer- and group-based,
interactive, analytical, customized, and accrediting program with didactic, training,
mentoring, administrative, and professional support to enhance clinical research knowledge
and skills among healthcare professionals, promote the generation of original research
projects, increase the chances of their successful completion and potential for meaningful
impact. The key features of the program are successive intra- and inter-group discussions
and confrontational thematic challenges among participating peers aimed at capitalizing
on the groups' collective knowledge, experience and skills, and combined intellectual
processing capabilities to optimize choice of research project elements and stakeholder
decision-making.
Type
Journal articleSubject
CREATEClinical Research Education (CRE)
educational program
research question
study design
workshops
Permalink
https://hdl.handle.net/10161/7769Collections
More Info
Show full item recordScholars@Duke
Tal Burt
Assistant Professor of Psychiatry and Behavioral Sciences
Tal Burt, MD is a Board-Certified psychiatrist and clinical researcher trained in
Israel, Italy, France, and the United States. After joining the faculty at the Department
of Psychiatry at Columbia University, Dr. Burt joined Pfizer Inc., and then Eisai
Pharmaceuticals, as Senior Medical Director with responsibilities in all phases of
clinical research and development. He then joined Duke and was the founding director
of the Investigational Medicine Unit (IMU) in Singapore and th
This author no longer has a Scholars@Duke profile, so the information shown here reflects
their Duke status at the time this item was deposited.

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info